{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:59:58Z","timestamp":1789689598412,"version":"4.0.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10072-020-04407-4","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T19:04:46Z","timestamp":1588359886000},"page":"2691-2701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Peripheral neuropathy in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"41","author":[{"given":"Dion A.","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rehman M.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Qayyum","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"key":"4407_CR1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jns.2017.05.023","volume":"378","author":"P Zis","year":"2017","unstructured":"Zis P, Gr\u00fcnewald RA, Chaudhuri RK, Hadjivassiliou M (2017) Peripheral neuropathy in idiopathic Parkinson\u2019s disease: a systematic review. J Neurol Sci 378:204\u2013209","journal-title":"J Neurol Sci"},{"key":"4407_CR2","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(04)16508-2","volume":"363","author":"JD England","year":"2004","unstructured":"England JD, Asbury AK (2004) Peripheral neuropathy. Lancet 363:2151\u20132161","journal-title":"Lancet"},{"issue":"9","key":"4407_CR3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/innovait\/inp129","volume":"2","author":"C Simon","year":"2009","unstructured":"Simon C (2009) Peripheral neuropathy. InnovAIT 2(9):538\u2013545","journal-title":"InnovAIT"},{"issue":"5","key":"4407_CR4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archneur.56.5.540","volume":"56","author":"GI Wolfe","year":"1999","unstructured":"Wolfe GI, Baker NS, Amato AA, Jackson CE, Nations SP, Saperstein DS, Cha CH, Katz JS, Bryan WW, Barohn RJ (1999) Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics. Arch Neurol 56(5):540\u2013547","journal-title":"Arch Neurol"},{"issue":"12","key":"4407_CR5","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.59.12_suppl_6.S2","volume":"59","author":"N Latov","year":"2002","unstructured":"Latov N (2002) Diagnosis of CIDP. Neurology 59(12):S2\u2013S6","journal-title":"Neurology"},{"key":"4407_CR6","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/jnnp.57.12.1525","volume":"57","author":"NC Notermans","year":"1994","unstructured":"Notermans NC, Wokke JH, van der Graaf Y (1994) Chronic idiopathic axonal polyneuropathy: a five year follow up. J Neurol Neurosurg Psychiatry 57:1525\u20131527","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4407_CR7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.parkreldis.2013.02.006","volume":"19","author":"T Muller","year":"2013","unstructured":"Muller T, Van Laar T, Cornblath DR et al (2013) Peripheral neuropathy in Parkinson\u2019s disease: levodopa exposure and implications for duodenal delivery. Parkinsonism Relat Disord 19:501\u2013507","journal-title":"Parkinsonism Relat Disord"},{"key":"4407_CR8","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1007\/s00415-013-7079-8","volume":"260","author":"YA Rajabelly","year":"2013","unstructured":"Rajabelly YA, Martey J (2013) Levodopa, vitamins, ageing and the neuropathy of Parkinson\u2019s disease. J Neurol 260:2844\u20132848","journal-title":"J Neurol"},{"key":"4407_CR9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2337\/diacare.27.1.168","volume":"27","author":"DR Leonard","year":"2004","unstructured":"Leonard DR, Farooqi MH, Myer S (2004) Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral neuropathy: a double-blind, randomized, placebo-controlled study with monochromatic near-infrared treatment. Diabetes Care 27:168\u2013172","journal-title":"Diabetes Care"},{"key":"4407_CR10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/ene.12846","volume":"23","author":"A Merola","year":"2016","unstructured":"Merola A, Romagnolo A, Zibetti M, Bernardini A, Cocito D, Lopiano L (2016) Peripheral neuropathy associated with levodopa\u2013carbidopa intestinal infusion: a long-term prospective assessment. Eur J Neurol 23:501\u2013509","journal-title":"Eur J Neurol"},{"key":"4407_CR11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1001\/archneur.1979.00500410086014","volume":"36","author":"E Melamed","year":"1979","unstructured":"Melamed E (1979) Early-morning dystonia: a late side effect of long-term levodopa therapy in Parkinson\u2019s disease. Arch Neurol 36:308\u2013310","journal-title":"Arch Neurol"},{"key":"4407_CR12","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.25585","volume":"28","author":"R Ceravolo","year":"2013","unstructured":"Ceravolo R, Cossu G, Bandettini M (2013) Neuropathy and levodopa in Parkinson\u2019s disease: evidence from a multicenter study. Mov Disord 28:1391\u20131397","journal-title":"Mov Disord"},{"key":"4407_CR13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.parkreldis.2013.11.001","volume":"20","author":"R Sakakibara","year":"2014","unstructured":"Sakakibara R, Tateno F, Kishi M, Tsuyusaki Y, Terada H, Inaoka T (2014) MIBG myocardial scintigraphy in pre-motor parkinson's disease: a review. Parkinsonism Relat Disord 20:267\u2013273","journal-title":"Parkinsonism Relat Disord"},{"key":"4407_CR14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/WNF.0b013e318283fa18","volume":"36","author":"T M\u00fcller","year":"2014","unstructured":"M\u00fcller T, Jugel C, Muhlack S, Klostermann F (2014) Methyl group\u2013donating vitamins elevate 3-O-methyldopa in patients with Parkinson disease. Clin Neuropharmacol 36:52\u201354","journal-title":"Clin Neuropharmacol"},{"key":"4407_CR15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ajcn\/72.2.315","volume":"72","author":"L Brattstrom","year":"2000","unstructured":"Brattstrom L, Wilcken DEL (2000) Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 72:315\u2013323","journal-title":"Am J Clin Nutr"},{"key":"4407_CR16","doi-asserted-by":"crossref","first-page":"1741S","DOI":"10.1093\/jn\/136.6.1741S","volume":"136","author":"H Jakubowski","year":"2006","unstructured":"Jakubowski H (2006) Pathophysiological consequences of homocysteine excess. J Nutr 136:1741S\u20131749S","journal-title":"J Nutr"},{"key":"4407_CR17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","volume":"26","author":"MP Mattson","year":"2003","unstructured":"Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137\u2013146","journal-title":"Trends Neurosci"},{"key":"4407_CR18","doi-asserted-by":"crossref","first-page":"15227","DOI":"10.1073\/pnas.93.26.15227","volume":"93","author":"TH Rosenquist","year":"1996","unstructured":"Rosenquist TH, Ratashak SA, Selhub J (1996) Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci U S A 93:15227\u201315232","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4407_CR19","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/jnnp-2017-316296","volume":"88","author":"EH Reynolds","year":"2017","unstructured":"Reynolds EH (2017) The risks of folic acid to the nervous system in vitamin B12 deficiency: rediscovered in the era of folic acid fortification policies. J Neurol Neurosurg Psychiatry 88:1097\u20131098","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4407_CR20","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3945\/jn.117.248278","volume":"147","author":"A Brito","year":"2017","unstructured":"Brito A, Grapov D, Fahrmann J, Harvey D, Green R, Miller JW, Fedosov SN, Shahab-Ferdows S, Hampel D, Pedersen TL, Fiehn O, Newman JW, Uauy R, Allen LH (2017) The human serum metabolome of vitamin B-12 deficiency and repletion, and associations with neurological function in elderly adults. J Nutr 147:1839\u20131849","journal-title":"J Nutr"},{"key":"4407_CR21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1353-8020(02)00114-1","volume":"9","author":"Y Okuma","year":"2003","unstructured":"Okuma Y, Hattori N, Mizuno Y (2003) Sensory neuropathy in autosomal recessive juvenile Parkinism (PARK 2). Parkinsonism Relat Disord 9:313\u2013314","journal-title":"Parkinsonism Relat Disord"},{"key":"4407_CR22","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/mds.20113","volume":"19","author":"G Abbruzzese","year":"2004","unstructured":"Abbruzzese G, Pigullo S, Schenone A, Bellone E, Marchese R, di Maria E, Benedetti L, Ciotti P, Nobbio L, Bonifati V, Ajmar F, Mandich P (2004) Does Parkin play a role in the peripheral nervous system? A family report. Mov Disord 19:978\u2013981","journal-title":"Mov Disord"},{"key":"4407_CR23","doi-asserted-by":"crossref","unstructured":"Jugel C, Ehlen F, Taskin B, Marzinzik F, M\u00fcller T, Klostermann F (2013) Neuropathy in Parkinson\u2019s disease patients with intestinal levodopa infusion versus oral drugs. PLoS One:e666\u2013e639","DOI":"10.1371\/journal.pone.0066639"},{"key":"4407_CR24","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00702-004-0262-4","volume":"112","author":"E Nissinen","year":"2005","unstructured":"Nissinen E, Nissinen H, Larjonmaa H, V\u00e4\u00e4n\u00e4nen A, Helkamaa T, Reenil\u00e4 I, Rauhala P (2005) The COMT inhibitor, entacapone, reduces levodopa-induced elevations in plasma homocysteine in healthy adult rats. J Neural Transm 112:1213\u20131221","journal-title":"J Neural Transm"},{"key":"4407_CR25","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.698","volume":"7","author":"S Loens","year":"2017","unstructured":"Loens S, Chorbadzhieva E, Kleimann A, Dressler D, Schrader C (2017) Effects of levodopa\/carbidopa intestinal gel versus oral levodopa\/carbidopa on B vitamin levels and neuropathy. Brain Behav 7:e00698","journal-title":"Brain Behav"},{"key":"4407_CR26","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/mds.23342","volume":"25","author":"PP Urban","year":"2010","unstructured":"Urban PP, Wellach I, Faiss S, Layer P, Rosenkranz T, Knop K, Weis J (2010) Subacute axonal neuropathy in Parkinson\u2019s disease with cobalamin and vitamin B6 deficiency under duodopa therapy. Mov Disord 25:1748\u20131752","journal-title":"Mov Disord"},{"issue":"2","key":"4407_CR27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/mds.23408","volume":"26","author":"AM Meppelink","year":"2011","unstructured":"Meppelink AM, Nyman R, van Laar T, Drent M, Prins T, Leenders KL (2011) Transcutaneous port for continuous duodenal levodopa\/carbidopa administration in Parkinson\u2019s disease. Mov Disord 26(2):331\u2013334","journal-title":"Mov Disord"},{"key":"4407_CR28","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/mds.21500","volume":"22","author":"A Antonini","year":"2007","unstructured":"Antonini A, Isaias IU, Canesi M, Zibetti M, Mancini F, Manfredi L, Dal Fante M, Lopiano L, Pezzoli G (2007) Duodenal levodopa infusion for advanced Parkinson\u2019s disease: 12- month treatment outcome. Mov Disord 22:1145\u20131149","journal-title":"Mov Disord"},{"key":"4407_CR29","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/mds.22807","volume":"24","author":"D Manca","year":"2009","unstructured":"Manca D, Cossu G, Murgia D, Molari A, Ferrigno P, Marcia E, Melis M (2009) Reversible encephalopathy and axonal neuropathy in Parkinson\u2019s disease during duodopa therapy. Mov Disord 24:2293\u20132294","journal-title":"Mov Disord"},{"key":"4407_CR30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.parkreldis.2013.08.007","volume":"20","author":"I Galazky","year":"2014","unstructured":"Galazky I, Schoof J, Stallforth S, Kupsch A, Heinze HJ, Kluge C (2014) Guillain\u2013Barre\/CIDP-like neuropathy in two Parkinsonian patients following intestinal levodopa\/carbidopa treatment. Parkinsonism Relat Disord 20:125\u2013127","journal-title":"Parkinsonism Relat Disord"},{"key":"4407_CR31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/ane.12164","volume":"129","author":"A Merola","year":"2014","unstructured":"Merola A, Zibetti M, Rizzone MG, Troiano M, Artusi CA, Angrisano S, Cocito D, Lopiano L (2014) Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients. Acta Neurol Scand 129:e1\u2013e5","journal-title":"Acta Neurol Scand"},{"key":"4407_CR32","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.26123","volume":"30","author":"HH Fernandez","year":"2015","unstructured":"Fernandez HH, Standaert DG, Hauser RA, Lang AE, Fung VS, Klostermann F, Lew MF, Odin P, Steiger M, Yakupov EZ, Chouinard S (2015) Levodopa-carbidopa intestinal gel in advanced Parkinson\u2019s disease: final 12-month, open-label results. Mov Disord 30:500\u2013509","journal-title":"Mov Disord"},{"key":"4407_CR33","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/s00415-011-6396-z","volume":"259","author":"D Santos-Garc\u00eda","year":"2012","unstructured":"Santos-Garc\u00eda D, de la Fuente-Fern\u00e1ndez R, Valldeoriola F, Palas\u00ed A, Carrillo F, Grande M, Mir P, De Fabregues O, Casanova J (2012) Polyneuropathy while on duodenal levodopa infusion in Parkinson\u2019s disease patients: we must be alert. J Neurol 259:1668\u20131672","journal-title":"J Neurol"},{"key":"4407_CR34","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ane.12783","volume":"136","author":"V Rispoli","year":"2017","unstructured":"Rispoli V, Simioni V, Capone JG, Golfr\u00e8 Andreasi N, Preda F, Sette E, Tugnoli V, Sensi M (2017) Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation. Acta Neurol Scand 136:660\u2013667","journal-title":"Acta Neurol Scand"},{"key":"4407_CR35","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/mus.25377","volume":"54","author":"G Devigili","year":"2016","unstructured":"Devigili G, Rinaldo S, Lettieri C, Eleopra R (2016) Levodopa\/carbidopa intestinal gel therapy for advanced Parkinson disease: AN early toxic effect for small nerve fibers? Muscle Nerve 54:970\u2013972","journal-title":"Muscle Nerve"},{"key":"4407_CR36","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/jnnp-2014-308586","volume":"86","author":"A Uncini","year":"2015","unstructured":"Uncini A, Eleopra R, Onofrj M (2015) Polyneuropathy associated with duodenal infusion of levodopa in Parkinson\u2019s disease: features, pathogenesis and management. J Neurol Neurosurg Psychiatry 86:490\u2013495","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4407_CR37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.parkreldis.2004.07.008","volume":"11","author":"S Zoccolella","year":"2005","unstructured":"Zoccolella S, Lamberti P, Armenise E, Mari M, Lamberti SV, Mastronardi R, Fraddosio A, Iliceto G, Livrea P (2005) Plasma homocysteine levels in Parkinson\u2019s disease: role of antiparkinsonian medications. Parkinsonism Relat Disord 11:131\u2013133","journal-title":"Parkinsonism Relat Disord"},{"key":"4407_CR38","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s003359900838","volume":"9","author":"P Goyette","year":"1998","unstructured":"Goyette P, Pai A, Milos R, Frosst P, Tran P, Chen Z, Chan M, Rozen R (1998) Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 9:652\u2013656","journal-title":"Mamm Genome"},{"key":"4407_CR39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12017-012-8174-1","volume":"14","author":"G Gorgone","year":"2012","unstructured":"Gorgone G, Curro M, Ferlazzo N, Parisi G, Parnetti L, Belcastro V, Tambasco N, Rossi A, Pisani F, Calabresi P, Ientile R (2012) Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson\u2019s disease patients. NeuroMolecular Med 14:84\u201390","journal-title":"NeuroMolecular Med"},{"key":"4407_CR40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","volume":"7","author":"AH Schapira","year":"2008","unstructured":"Schapira AH (2008) Mitochondria in the aetiology and pathogenesis of Parkinson\u2019s disease. Lancet Neurol 7:97\u2013109","journal-title":"Lancet Neurol"},{"key":"4407_CR41","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","volume":"283","author":"L Devi","year":"2008","unstructured":"Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK (2008) Mitochondrial import and accumulation of \u03b1-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283:9089\u20139100","journal-title":"J Biol Chem"},{"key":"4407_CR42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","volume":"76","author":"K Wakabayashi","year":"1988","unstructured":"Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1988) Parkinson\u2019s disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol 76:217\u2013221","journal-title":"Acta Neuropathol"},{"key":"4407_CR43","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J (2009 Jun 1) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613\u2013634","journal-title":"Acta Neuropathol"},{"key":"4407_CR44","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(04)16983-3","volume":"364","author":"P Luoma","year":"2004","unstructured":"Luoma P, Melberg A, Rinne JO (2004) Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364:875\u2013882","journal-title":"Lancet"},{"key":"4407_CR45","volume":"8","author":"S Liu","year":"2012","unstructured":"Liu S, Sawada T, Lee S, Yu W, Silverio G, Alapatt P, Millan I, Shen A, Saxton W, Kanao T, Takahashi R, Hattori N, Imai Y, Lu B (2012) Parkinson\u2019s disease \u2013 associated kinase PINK1 regulates axonal transport of mitochondria. PLoS Genet 8:e1002537","journal-title":"PLoS Genet"},{"key":"4407_CR46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4407_CR47","doi-asserted-by":"crossref","first-page":"e1169","DOI":"10.1007\/s00702-005-0431-0","volume":"113","author":"R Dabby","year":"2006","unstructured":"Dabby R, Djaldetti R, Shahmurov M, Treves TA, Gabai B, Melamed E et al (2006) Skin biopsy for assessment of autonomic denervation in Parkinson's disease. J Neural Transm 113:e1169\u2013e1176","journal-title":"J Neural Transm"},{"key":"4407_CR48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","volume":"5","author":"E Tolosa","year":"2006","unstructured":"Tolosa E, Wenning G, Poewe W (2006) The diagnosis of Parkinson\u2019s disease. Lancet Neurol 5:75\u201386","journal-title":"Lancet Neurol"},{"key":"4407_CR49","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/brain\/awn102","volume":"131","author":"M Nolano","year":"2008","unstructured":"Nolano M, Provitera V, Estraneo A, Selim MM, Caporaso G, Stancanelli A, Saltalamacchia AM, Lanzillo B, Santoro L (2008) Sensory deficit in Parkinson\u2019s disease: evidence of a cutaneous denervation. Brain 131:1903\u20131911","journal-title":"Brain"},{"key":"4407_CR50","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/mds.20594","volume":"20","author":"S Orimo","year":"2005","unstructured":"Orimo S, Amino T, Yokochi M, Kojo T, Uchihara T, Takahashi A, Wakabayashi K, Takahashi H, Hattori N, Mizuno Y (2005) Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2. Mov Disord 20:1350\u20131353","journal-title":"Mov Disord"},{"key":"4407_CR51","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/jnnp.73.6.776","volume":"73","author":"S Orimo","year":"2002","unstructured":"Orimo S, Oka T, Miura H, Tsuchiya K, Mori F, Wakabayashi K, Nagao T, Yokochi M (2002) Sympathetic cardiac denervation in Parkinson\u2019s disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry 73:776\u2013777","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4407_CR52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, del Tredici K, R\u00fcb U, De Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"4407_CR53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Del Tredici","year":"2002","unstructured":"Del Tredici K, R\u00fcb U, De Vos RA, Bohl JR, Braak H (2002) Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413\u2013426","journal-title":"J Neuropathol Exp Neurol"},{"key":"4407_CR54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1750-3639.2006.00032.x","volume":"17","author":"S Orimo","year":"2007","unstructured":"Orimo S, Takahashi A, Uchihara T, Mori F, Kakita A, Wakabayashi K, Takahashi H (2007) Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol 17:24\u201330","journal-title":"Brain Pathol"},{"key":"4407_CR55","doi-asserted-by":"crossref","first-page":"e1362","DOI":"10.1212\/WNL.0000000000000316","volume":"82","author":"V Donadio","year":"2014","unstructured":"Donadio V, Incensi A, Leta V, Giannoccaro MP, Scaglione C, Martinelli P et al (2014) Skin nerve alpha-synuclein deposits: a biomarker for idiopathic Parkinson disease. Neurology 82:e1362\u2013e1369","journal-title":"Neurology"},{"key":"4407_CR56","doi-asserted-by":"crossref","first-page":"e1085","DOI":"10.1002\/mds.21989","volume":"23","author":"H Fujishiro","year":"2008","unstructured":"Fujishiro H, Frigerio R, Burnett M, Klos KJ, Josephs KA, Delledonne A et al (2008) Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson\u2019s disease. Mov Disord 23:e1085\u2013e1092","journal-title":"Mov Disord"},{"key":"4407_CR57","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1371\/journal.pone.0012728","volume":"5","author":"T Lebouvier","year":"2010","unstructured":"Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, N'Guyen JM et al (2010) Colonic biopsies to assess the neuropathology of Parkinson\u2019s disease and its relationship with symptoms. PLoS One 5:e127\u2013e128","journal-title":"PLoS One"},{"key":"4407_CR58","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1007\/s00401-014-1284-0","volume":"128","author":"K Doppler","year":"2014","unstructured":"Doppler K, Ebert S, Uceyler N, Trenkwalder C, Ebentheuer J, Volkmann J et al (2014) Cutaneous neuropathy in Parkinson\u2019s disease: a window into brain pathology. Acta Neuropathol 128:e99\u2013e109","journal-title":"Acta Neuropathol"},{"key":"4407_CR59","doi-asserted-by":"crossref","first-page":"e1604","DOI":"10.1212\/WNL.0b013e3182a9f449","volume":"81","author":"N Wang","year":"2013","unstructured":"Wang N, Gibbons CH, Lafo J, Freeman R (2013) Alpha-synuclein in cutaneous autonomic nerves. Neurology 81:e1604\u2013e1610","journal-title":"Neurology"},{"key":"4407_CR60","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.24567","volume":"79","author":"V Donadio","year":"2016","unstructured":"Donadio V, Incensi A, Piccinini C, Cortelli P, Giannoccaro MP, Baruzzi A, Liguori R (2016) Skin nerve misfolded \u03b1-synuclein in pure autonomic failure and Parkinson disease. Ann Neurol 79:306\u2013316","journal-title":"Ann Neurol"},{"key":"4407_CR61","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ana.22258","volume":"68","author":"A Gondim Fde","year":"2010","unstructured":"Gondim Fde A, de Oliveira GR, Peixoto AA Jr, Horta WG (2010) A case series of peripheral neuropathy in patients with Parkinson\u2019s disease. Ann Neurol 68:973\u2013975","journal-title":"Ann Neurol"},{"key":"4407_CR62","doi-asserted-by":"crossref","first-page":"e1947","DOI":"10.1212\/WNL.0b013e31823a0ee4","volume":"77","author":"YA Rajabally","year":"2011","unstructured":"Rajabally YA, Martey J (2011) Neuropathy in Parkinson disease: prevalence and determinants. Neurology 77:e1947\u2013e1950","journal-title":"Neurology"},{"key":"4407_CR63","first-page":"S720","volume":"25","author":"G Gusmaroli","year":"2010","unstructured":"Gusmaroli G, Barbagli D, Ravagnani M, Mongiovetti M, Capone L, Tarletti R et al (2010) Axonal polyneuropathy during duodenal levodopa treatment in a woman with idiopathic Parkinson\u2019s disease. Mov Disord 25:S720","journal-title":"Mov Disord"},{"key":"4407_CR64","unstructured":"Palas\u00ed A, F\u00e1bregues O, Hern\u00e1ndez-Vara J, Seoane JL, G\u00e1mez J, \u00c1lvarez-Sab\u00edn J. Small fiber peripheral neuropathy presentation after starting treatment with continuous intraduodenal levodopa infusion in one patient with Parkinson disease. In: Poster presentation at: 7th international congress on mental dysfunction and other non-motor features in Parkinson\u2019s disease 2010"},{"key":"4407_CR65","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1007\/s00702-011-0689-3","volume":"119","author":"F Klostermann","year":"2012","unstructured":"Klostermann F, Jugel C, M\u00fcller T, Marzinzik F (2012) Malnutritional neuropathy under intestinal levodopa infusion. J Neural Transm 119:e369\u2013e372","journal-title":"J Neural Transm"},{"key":"4407_CR66","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/mds.22137","volume":"23","author":"C Toth","year":"2008","unstructured":"Toth C, Brown MS, Furtado S, Suchowersky O, Zochodne D (2008) Neuropathy as a potential complication of levodopa use in Parkinson\u2019s disease. Mov Disord 23:1850\u20131859","journal-title":"Mov Disord"},{"issue":"1","key":"4407_CR67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.15171\/jlms.2020.05","volume":"11","author":"AA Shanb","year":"2020","unstructured":"Shanb AA, Youssef EF, Al Baker WI, Al-Khamis FA, Hassan A, Jatoi NA (2020) The efficacy of adding electromagnetic therapy or laser therapy to medications in patients with diabetic peripheral neuropathy. J Lasers Med Sci 11(1):20\u201328","journal-title":"J Lasers Med Sci"},{"key":"4407_CR68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.parkreldis.2016.04.016","volume":"27","author":"G Cossu","year":"2016","unstructured":"Cossu G, Ceravolo R, Zibetti M, Arca R, Ricchi V, Paribello A, Murgia D, Merola A, Romagnolo A, Nicoletti V, Palermo G (2016) Levodopa and neuropathy risk in patients with Parkinson disease: effect of COMT inhibition. Parkinsonism Relat Disord 27:81\u201384","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"4407_CR69","first-page":"48","volume":"14","author":"T Sun","year":"2005","unstructured":"Sun T et al (2005) Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials. Acta Neurol Taiwan 14(2):48\u201354","journal-title":"Acta Neurol Taiwan"},{"key":"4407_CR70","doi-asserted-by":"crossref","first-page":"113281","DOI":"10.1016\/j.expneurol.2020.113281","volume":"5","author":"C Picci","year":"2020","unstructured":"Picci C, Wong VS, Costa CJ, McKinnon MC, Goldberg DC, Swift M, Alam NM, Prusky GT, Shen S, Kozikowski AP, Willis DE (2020) HDAC6 inhibition promotes \u03b1-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice. Exp Neurol 5:113281","journal-title":"Exp Neurol"},{"issue":"9","key":"4407_CR71","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.4103\/1673-5374.276321","volume":"15","author":"A Lazic","year":"2020","unstructured":"Lazic A, Popovi\u0107 J, Paunesku T, Woloschak GE, Stevanovi\u0107 M (2020) Insights into platinum-induced peripheral neuropathy\u2013current perspective. Neural Regen Res 15(9):1623\u20131630","journal-title":"Neural Regen Res"},{"key":"4407_CR72","doi-asserted-by":"crossref","first-page":"116777","DOI":"10.1016\/j.jns.2020.116777","volume":"413","author":"F Massa","year":"2020","unstructured":"Massa F, Zuppa A, Pesce G, Demichelis C, Bergamaschi M, Garnero M, Briani C, Ferrari S, Schenone A, Benedetti L (2020) Bendamustine\u2013rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy. J Neurol Sci 413:116777","journal-title":"J Neurol Sci"},{"key":"4407_CR73","first-page":"1","volume":"5","author":"MS Prnova","year":"2019","unstructured":"Prnova MS, Kovacikova L, Svik K, Bezek S, Elmazo\u011flu Z, Karasu C, Stefek M (2019) Triglyceride-lowering effect of the aldose reductase inhibitor cemtirestat\u2014another factor that may contribute to attenuation of symptoms of peripheral neuropathy in STZ-diabetic rats. Naunyn Schmiedeberg's Arch Pharmacol 5:1\u20131","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"4407_CR74","doi-asserted-by":"crossref","first-page":"117557","DOI":"10.1016\/j.lfs.2020.117557","volume":"14","author":"SE Elkholy","year":"2020","unstructured":"Elkholy SE, Elaidy SM, El-Sherbeeny NA, Toraih EA, Elgawly HW (2020) Neuroprotective effects of ranolazine versus pioglitazone in experimental diabetic neuropathy: targeting Nav1. 7 channels and PPAR-\u03b3. Life Sci 14:117557","journal-title":"Life Sci"},{"key":"4407_CR75","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jmu.2015.02.001","volume":"23","author":"CH Chen","year":"2015","unstructured":"Chen CH, Huang YK, Jaw FS (2015) Ultrasound-guided perineural vitamin b12 injection for peripheral neuropathy. J Med Ultrasound 23:104\u2013106","journal-title":"J Med Ultrasound"},{"key":"4407_CR76","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.gaitpost.2005.04.002","volume":"23","author":"A Nardone","year":"2006","unstructured":"Nardone A, Grasso M, Schieppati M (2006) Balance control in peripheral neuropathy: are patients equally unstable under static and dynamic conditions? Gait Posture 23:364\u2013373","journal-title":"Gait Posture"},{"key":"4407_CR77","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrneurol.2012.97","volume":"8","author":"JG Hoeijmakers","year":"2012","unstructured":"Hoeijmakers JG, Faber CG, Lauria G, Merkies IS, Waxman SG (2012) Small-fibre neuropathies \u2013 advances in diagnosis, pathophysiology and management. Nat Rev Neurol 8:369\u2013379","journal-title":"Nat Rev Neurol"},{"key":"4407_CR78","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.parkreldis.2012.06.022","volume":"18","author":"D Nyholm","year":"2012","unstructured":"Nyholm D (2012) Duodopa\u00ae treatment for advanced Parkinson\u2019s disease: a review of efficacy and safety. Parkinsonism Relat Disord 18:916\u2013929","journal-title":"Parkinsonism Relat Disord"},{"key":"4407_CR79","first-page":"14","volume":"5","author":"D Yeager","year":"2012","unstructured":"Yeager D (2012) Diagnosing peripheral neuropathy. Aging Well 5:14","journal-title":"Aging Well"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04407-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04407-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04407-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T09:03:09Z","timestamp":1620032589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04407-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":79,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4407"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04407-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]},"assertion":[{"value":"11 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol conforms to the provisions of the Declaration of Helsinki 1995, revised in Tokyo in 2004. We confirm that we have read the Journal\u2019s position on\u00a0ethical publication and affirm that this report is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}